Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Virus-based vectors for human vaccine applications.

John M Polo1, Thomas W Dubensky

  • 1Chiron Corporation, Immunology and Infectious Diseases, 4560 Horton St, Emeryville, CA 94608, USA. john_polo@chiron.com

Drug Discovery Today
|July 12, 2002
PubMed
Summary

Gene-based vaccines using viral vectors offer a promising alternative to traditional methods for diseases like HIV and Hepatitis C. These advanced vaccines stimulate robust immune responses, enhancing antigen presentation for better protection.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

First-in-human Phase I Trial of TPST-1120, an Inhibitor of PPARα, as Monotherapy or in Combination with Nivolumab, in Patients with Advanced Solid Tumors.

Cancer research communications·2024
Same author

Dual Blockade of EP2 and EP4 Signaling is Required for Optimal Immune Activation and Antitumor Activity Against Prostaglandin-Expressing Tumors.

Cancer research communications·2023
Same author

Correction: Phase I Dose-Escalation Trial of MIW815 (ADU-S100), an Intratumoral STING Agonist, in Patients with Advanced/Metastatic Solid Tumors or Lymphomas.

Clinical cancer research : an official journal of the American Association for Cancer Research·2023
Same author

Magnitude of Therapeutic STING Activation Determines CD8<sup>+</sup> T Cell-Mediated Anti-tumor Immunity.

Cell reports·2019
Same author

A Potent and Effective Suicidal <i>Listeria</i> Vaccine Platform.

Infection and immunity·2019
Same author

Cyclic Dinucleotide-Adjuvanted Dengue Virus Nonstructural Protein 1 Induces Protective Antibody and T Cell Responses.

Journal of immunology (Baltimore, Md. : 1950)·2019

Area of Science:

  • Immunology and Vaccinology
  • Molecular Biology
  • Virology

Background:

  • Traditional vaccine methods face limitations for certain diseases, including HIV and Hepatitis C.
  • Gene-based vaccines show potential for stimulating strong humoral and cellular immunity.

Purpose of the Study:

  • To explore the efficacy of gene-based vaccines utilizing viral vectors.
  • To highlight the advantages of viral vectors in vaccine development and antigen presentation.

Main Methods:

  • Development and evaluation of diverse viral vectors for gene delivery.
  • Assessment of immune responses stimulated by gene-based vaccines in preclinical and clinical studies.

Main Results:

  • Viral vectors efficiently deliver antigen-encoding genes.

Related Experiment Videos

  • Gene-based vaccines stimulate potent humoral and cellular immune responses.
  • Viral vectors enhance antigen presentation.

    • Conclusions:

    • Virus-based vaccines are a promising strategy for infectious and malignant diseases.
    • Gene-based vaccines represent a significant advancement in vaccinology.
    • Viral vectors offer an effective platform for next-generation vaccine development.